Which procedure is a definitive surgical treatment for acquired NLDO?

Prepare for the Certified Paraoptometric Assistant (CPOA) Exam. Study with extensive flashcards and multiple choice questions with explanations. Enhance your skills and knowledge to succeed.

Multiple Choice

Which procedure is a definitive surgical treatment for acquired NLDO?

Explanation:
Creating a new drainage pathway from the lacrimal sac to the nasal cavity is the definitive surgical treatment for acquired NLDO. Dacryocystorhinostomy establishes a direct bypass around the blocked nasolacrimal duct by forming a rhinostomy between the lacrimal sac and the nasal cavity, allowing tears to drain into the nose. This approach addresses the actual site of obstruction and has high success rates in adults with acquired NLDO, whether done externally or endoscopically. Removing the lacrimal sac (dacryocystectomy) eliminates the sac but does not restore tear drainage, so it is not a definitive treatment for NLDO. Canaliculotomy targets the canaliculi, not the distal nasolacrimal duct obstruction, so it doesn’t resolve acquired NLDO. Conjunctival biopsy is a diagnostic procedure for ocular surface conditions, not a therapeutic solution for NLDO.

Creating a new drainage pathway from the lacrimal sac to the nasal cavity is the definitive surgical treatment for acquired NLDO. Dacryocystorhinostomy establishes a direct bypass around the blocked nasolacrimal duct by forming a rhinostomy between the lacrimal sac and the nasal cavity, allowing tears to drain into the nose. This approach addresses the actual site of obstruction and has high success rates in adults with acquired NLDO, whether done externally or endoscopically. Removing the lacrimal sac (dacryocystectomy) eliminates the sac but does not restore tear drainage, so it is not a definitive treatment for NLDO. Canaliculotomy targets the canaliculi, not the distal nasolacrimal duct obstruction, so it doesn’t resolve acquired NLDO. Conjunctival biopsy is a diagnostic procedure for ocular surface conditions, not a therapeutic solution for NLDO.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy